XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.3
Net Income Per Share
 9 Months Ended
Oct. 01, 2024
Net Income Per Share  
Net Income Per Share

10.   Net Income Per Share

​

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, reduced by unvested restricted stock awards. As of October 1, 2024 and October 3, 2023, 3.2 million and 2.8 million shares, respectively, of restricted stock and restricted stock units issued were unvested and, therefore, excluded from the calculation of basic earnings per share for the fiscal periods ended on those dates.

​

Diluted net income per share is computed by dividing net income by the weighted-average number of common stock equivalents outstanding for the period. Common stock equivalents for the Notes are determined by application of the if-converted method, and common stock equivalents for outstanding stock options, restricted stock and restricted stock units are determined by the application of the treasury stock method.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Thirteen

​

Thirteen

​

Thirty-Nine

​

Thirty-Nine

​

​

Weeks Ended

​

Weeks Ended

​

Weeks Ended

​

Weeks Ended

​

    

October 1, 2024

    

October 3, 2023

    

October 1, 2024

    

October 3, 2023

​

​

(In thousands, except per share data)

Net income

​

$

29,994

​

$

17,945

​

$

115,629

​

$

88,670

​

​

​

​

​

​

​

​

​

​

​

​

​

Basic weighted-average shares outstanding

​

​

47,750

​

​

48,281

​

​

47,734

​

​

48,489

Dilutive effect of equity awards (1)

​

​

1,196

​

​

704

​

​

1,017

​

​

708

Diluted weighted-average shares outstanding

​

​

48,946

​

​

48,985

​

​

48,751

​

​

49,197

​

​

​

​

​

​

​

​

​

​

​

​

​

Basic net income per share

​

$

0.63

​

$

0.37

​

$

2.42

​

$

1.83

​

​

​

​

​

​

​

​

​

​

​

​

​

Diluted net income per share

​

$

0.61

​

$

0.37

​

$

2.37

​

$

1.80

(1)Shares of common stock equivalents related to outstanding stock options, restricted stock and restricted stock units of 2.7 million and 2.8 million for October 1, 2024 and October 3, 2023, were excluded from the diluted calculation due to their anti-dilutive effect. No shares of common stock equivalents related to the Notes were included in the diluted calculation due to their anti-dilutive effect.